Karyopharm Therapeutics, Inc. (KPTI)
8.85
-0.06
(-0.73%)
USD |
NASDAQ |
May 13, 16:00
8.85
0.00 (0.00%)
After-Hours: 16:08
Karyopharm Therapeutics Free Cash Flow : -75.37M for Dec. 31, 2025
Free Cash Flow Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Free Cash Flow Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Free Cash Flow Benchmarks
| Gilead Sciences, Inc. | 10.23B |
| Catalyst Pharmaceuticals, Inc. | 208.13M |
| Alnylam Pharmaceuticals, Inc. | 641.34M |
| Oncolytics Biotech, Inc. | -19.96M |
| Agios Pharmaceuticals, Inc. | -384.73M |
Free Cash Flow Related Metrics
| Cash from Operations (Quarterly) | -11.83M |
| Cash from Investing (Quarterly) | 5.00M |
| Cash from Financing (Quarterly) | 29.69M |
| Free Cash Flow Per Share (Quarterly) | -0.6606 |
| Free Cash Flow to Equity (Quarterly) | -49.01M |
| Free Cash Flow to Firm (Quarterly) | 0.7827M |
| Free Cash Flow Yield | -78.02% |